ArticleImmunoHorizons2023

A Novel Humanized PD-1/PD-L1 Mouse Model Permits Direct Comparison of Antitumor Immunity Generated by Food and Drug Administration-Approved PD-1 and PD-L1 Inhibitors.

Whitney Barham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.